Does Medicare cover Wegovy for weight loss in 2026?

Yes. Starting July 2026, the Medicare GLP-1 Bridge covers Wegovy for chronic weight management at a flat $50 per month for eligible seniors. Before the Bridge, Medicare did not cover any drug used purely for weight loss.

How much does Wegovy cost with Medicare?

Under the GLP-1 Bridge, Wegovy costs a flat $50 per month for eligible seniors. Without coverage, the cash price exceeds $1,300 per month, so the Bridge saves qualifying seniors more than $15,000 a year.

Do I need diabetes to get Wegovy covered by Medicare?

No. The GLP-1 Bridge covers Wegovy for weight management based on BMI, not blood sugar. You generally need a BMI of 30 or higher, or 27 or higher with a weight-related condition. A diabetes diagnosis is not required.

What is the difference between Wegovy and Ozempic on Medicare?

Both contain semaglutide, but Medicare covers Ozempic only for type 2 diabetes under standard Part D, while Wegovy is approved for weight management and is covered by the $50 GLP-1 Bridge. Ask your doctor for Wegovy by name for weight-management coverage.

Do I need prior authorization for Wegovy on Medicare?

Yes. Your plan typically requires prior authorization, where your provider documents your BMI and any weight-related conditions before the $50 Bridge cost-share applies.

Does Medicare Cover Wegovy in 2026?

The Short Answer

Yes — Medicare covers Wegovy in 2026, but through a specific new pathway, not standard Part D weight-loss coverage. Beginning July 2026, the Medicare GLP-1 Bridge covers Wegovy for chronic weight management at a flat $50 per month for seniors who meet the eligibility rules.

This is a real change. For years, Medicare was legally barred from covering any drug used purely for weight loss — Wegovy included. The Bridge is what flipped that. So if you have heard conflicting answers, both were once true: Medicare did not cover Wegovy for weight loss for years, and now — under the Bridge — it does for those who qualify.

Not sure whether you qualify? Our eligibility quiz walks you through it in two minutes.

What Is Wegovy?

Wegovy is a brand-name once-weekly injection from Novo Nordisk. Its active ingredient is semaglutide — the same GLP-1 receptor agonist found in Ozempic — but Wegovy is dosed higher and is FDA-approved specifically for chronic weight management, not diabetes.

That weight-management approval is the key that unlocks Bridge coverage. Wegovy also carries an FDA indication to reduce cardiovascular risk in certain adults with obesity, plus a newer indication for moderate-to-severe obstructive sleep apnea — which can open additional coverage routes. (See Does Medicare cover Wegovy for sleep apnea? for that pathway.)

How Medicare Covers Wegovy in 2026

Coverage runs through your Medicare Part D drug plan — or the drug portion of a Medicare Advantage (MA-PD) plan. Under the GLP-1 Bridge, eligible weight-management drugs sit on plan formularies at a standardized $50 monthly cost-share, rather than the normal tiered copay that would otherwise make them unaffordable.

The Bridge currently covers three weight-management GLP-1 drugs: Wegovy, Zepbound, and Foundayo. Ozempic is not on that list, because it is approved for diabetes rather than weight loss — an important distinction we explain below.

Who Qualifies for Wegovy Coverage

To get Wegovy covered under the Bridge, you generally need to:

Be enrolled in a Medicare Part D or MA-PD plan
Meet the BMI threshold — typically a BMI of 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure, heart disease, or sleep apnea
Have a prescription from a Medicare-accepting provider
Complete prior authorization with your plan

You do not need a diabetes diagnosis to qualify — the Bridge is built around weight management, not blood sugar. If you need help finding a prescriber, our provider directory lists clinicians who accept Medicare.

What Wegovy Costs on Medicare

Under the Bridge, Wegovy costs a flat $50 per month for eligible seniors. Without coverage, the cash price runs well over $1,300 per month — so the Bridge represents savings of more than $15,000 a year for people who qualify.

For a full cost breakdown, including deductible interactions and what happens if your plan denies the claim, see How much does Wegovy cost on Medicare in 2026?.

Wegovy vs Ozempic: Why the Name Matters

Here is the single most common mistake seniors make: they ask their doctor for Ozempic because it is the name they have heard, but the prescription that unlocks Bridge coverage is Wegovy.

Both contain semaglutide. But Medicare covers Ozempic only for type 2 diabetes under standard Part D, while Wegovy — approved for weight management — is what the $50 Bridge covers. Asking for the wrong one can mean a denied claim. Read Does Medicare cover Ozempic in 2026? and our full Ozempic vs Wegovy vs Zepbound comparison before your appointment.

How to Get Wegovy Covered — Step by Step

Confirm your eligibility. Check your BMI and Part D enrollment with the eligibility quiz.
Find a Medicare-accepting prescriber. Use the provider directory to locate one near you.
Ask for Wegovy by name — not Ozempic — for weight management.
Complete prior authorization. Your provider documents your BMI and any related conditions. See GLP-1 prior authorization on Medicare for what to expect.
Fill at your pharmacy and confirm the $50 Bridge cost-share applied.

Data Note

Data as of May 2026. The Medicare GLP-1 Bridge is scheduled to launch in July 2026, and coverage specifics are set by CMS and your individual plan. Always confirm current rules with your plan or Medicare.gov before making decisions.

For the bigger picture on every weight-loss drug Medicare is set to cover next year, see Will Medicare cover weight loss drugs in 2026?